Phlow Stock
Phlow is a public benefit pharmaceutical company that develops and manufactures critical active pharmaceutical ingredients (APIs) and finished dosage forms entirely within the U.S. to strengthen national medicine supply chains and reduce dependence on foreign producers.
Founded: 2020
For more Phlow stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| Eric Edwards Chief Executive Officer |
| Dan Hackman President |
| Dave Ryan Chief Financial Officer |
| Andrew Carpenter Chief Scientific Officer |
